SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-026070
Filing Date
2019-05-14
Accepted
2019-05-14 17:17:13
Documents
54
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv521138_10q.htm 10-Q 377919
2 EXHIBIT 31.1 tv521138_ex31-1.htm EX-31.1 10372
3 EXHIBIT 31.2 tv521138_ex31-2.htm EX-31.2 10390
4 EXHIBIT 32.1 tv521138_ex32-1.htm EX-32.1 3936
5 EXHIBIT 32.2 tv521138_ex32-2.htm EX-32.2 4204
  Complete submission text file 0001144204-19-026070.txt   2607388

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cycc-20190331.xml EX-101.INS 394201
7 XBRL TAXONOMY EXTENSION SCHEMA cycc-20190331.xsd EX-101.SCH 30438
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cycc-20190331_cal.xml EX-101.CAL 34878
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20190331_def.xml EX-101.DEF 119216
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20190331_lab.xml EX-101.LAB 315117
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20190331_pre.xml EX-101.PRE 208918
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 19823880
SIC: 2834 Pharmaceutical Preparations